A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

The analyst further reasoned that the high ocular toxicity rates, including keratopathy and visual acuity changes, are ...

Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) fell 3.2% in the afternoon session after ...

Arbitrators cleared the way for the long-delayed $53 billion acquisition after Exxon tried to pre-empt the deal. 3M raised its full-year earnings outlook after beating expectations in the second ...